alvotech

Alvotech Reports Record Results for 2024 and Provides Business UpdateAlvotech Reports Record Results for 2024 and Provides Business Update

Alvotech Reports Record Results for 2024 and Provides Business Update

Total Revenues in 2024 reached $492 million, representing a 427% increase over prior yearProduct Revenues in 2024 reached $273 million,…

1 month ago
Alvotech Acquires Xbranes R&D Operations in Swedenand Further Affirms its Global Leadership Positionin Biosimilars Development and ProductionAlvotech Acquires Xbranes R&D Operations in Swedenand Further Affirms its Global Leadership Positionin Biosimilars Development and Production

Alvotech Acquires Xbranes R&D Operations in Swedenand Further Affirms its Global Leadership Positionin Biosimilars Development and Production

REYKJAVIK, Iceland and STOCKHOLM, March 20, 2025 (GLOBE NEWSWIRE) --  Alvotech (NASDAQ: ALVO), a global biotech company specializing in the…

1 month ago
Alvotech Acquires Xbranes R&D Operations in Sweden and Further Affirms its Global Leadership Position in Biosimilars Development and ProductionAlvotech Acquires Xbranes R&D Operations in Sweden and Further Affirms its Global Leadership Position in Biosimilars Development and Production

Alvotech Acquires Xbranes R&D Operations in Sweden and Further Affirms its Global Leadership Position in Biosimilars Development and Production

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today…

1 month ago
Teva and Alvotech Announce SELARSDI (ustekinumab-aekn) Injection Now Available in the U.S.Teva and Alvotech Announce SELARSDI (ustekinumab-aekn) Injection Now Available in the U.S.

Teva and Alvotech Announce SELARSDI (ustekinumab-aekn) Injection Now Available in the U.S.

In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference product Stelara®…

2 months ago
Alvotech Added to Nasdaq Biotech Index Effective Monday December 23, 2024Alvotech Added to Nasdaq Biotech Index Effective Monday December 23, 2024

Alvotech Added to Nasdaq Biotech Index Effective Monday December 23, 2024

Addition is part of the annual reconstitution of the Nasdaq Biotech Index (NBI)Inclusion criteria include minimum market capitalization and daily…

4 months ago
Alvotech Added to Nasdaq Biotech Index Effective Monday December 23, 2024Alvotech Added to Nasdaq Biotech Index Effective Monday December 23, 2024

Alvotech Added to Nasdaq Biotech Index Effective Monday December 23, 2024

Addition is part of the annual reconstitution of the Nasdaq Biotech Index (NBI)Inclusion criteria include minimum market capitalization and daily…

4 months ago